Carbamoyl-phosphate synthetase 1 deficiency

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Carbamoyl-phosphate synthetase 1 deficiency.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Carbamoyl-phosphate synthetase 1 deficiency.
Check the disease page for updates →

Approved Treatments

2 FDA-approved

Sodium Phenylbutyrate

(SODIUM PHENYLBUTYRATE TABLETS, 500 MG)Orphan drugstandard

ENDO USA, Inc.

FDA label ↗

Sodium Phenylbutyrate

(SODIUM PHENYLBUTYRATE)Orphan drugstandard

GLENMARK PHARMACEUTICALS INC., USA

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Carbamoyl-phosphate synthetase 1 deficiency.
Search all trials →
Search clinical trials for Carbamoyl-phosphate synthetase 1 deficiency

Recent News & Research

No recent news articles indexed yet for Carbamoyl-phosphate synthetase 1 deficiency.
Search PubMed for Carbamoyl-phosphate synthetase 1 deficiency

Browse all Carbamoyl-phosphate synthetase 1 deficiency news →

Specialist Network

Top 6 by expertise

View all Carbamoyl-phosphate synthetase 1 deficiency specialists →

Quick Actions